文献速递临床生化临床血液与体液质量管理与危急值

频繁校准是否足够?基于患者数据的血气与实验室分析仪质量控制视角

Are frequent calibrations enough? A patient-based quality control perspective on blood gas and laboratory analyzers.
PubMed 文献 · Clin Chim Acta · 2025-10-10

本研究回顾性收集三个月内中央实验室分析仪与床旁血气分析仪的患者葡萄糖、钠和血红蛋白结果,共112,898条,采用基于患者数据的质量控制(PBQC)指标比较分析性能。结果显示中央实验室分析仪假阳性报警率更低,血气分析仪虽频繁自动校准但假阳性报警更多,PBQC可有效补充常规质控并早期发现分析偏差。

要点

  • PBQC可补充常规质控,早期检测中央实验室和床旁分析仪的分析偏差。
  • 血气分析仪频繁自动校准仍产生更多假阳性报警,中央实验室分析仪性能更稳定。
  • 建议将PBQC算法整合入血气分析仪软件,以偏差触发校准而非固定时间间隔。

核心结论

  • PBQC可有效补充常规质控,早期检测中央实验室和床旁分析仪的分析偏差。
  • 血气分析仪虽频繁自动校准但假阳性报警更多,中央实验室分析仪性能更稳定。
  • 建议将基于PBQC的算法整合入血气分析仪软件,以观察到的偏差触发校准而非固定时间间隔。

研究设计与样本

  • 回顾性研究,收集Ümraniye培训与研究医院三个月(5月至7月)的患者葡萄糖、钠和血红蛋白结果。
  • 数据来自中央实验室分析仪(Roche COBAS 8000、Mindray BC6000)和床旁血气分析仪(Siemens Rapidpoint 500)。
  • 应用基于参考区间(RI)、RCVG和离群值Q检验的三种截断方法后,共纳入112,898条结果。
  • 采用指数加权移动平均(EWMA)图(λ=0.05)进行PBQC分析,评估假阳性报警率和误差检测前平均患者结果数(ANPed),遵循IFCC推荐。
  • 从室内质控(IQC)数据计算误差检测概率(Ped)。

主要发现

  • PBQC分析显示中央实验室分析仪的假阳性报警率持续低于血气分析仪。
  • 两种设备类型的ANPed值均较低,表明有效的误差检测能力。
  • Rapidpoint分析仪的葡萄糖和COBAS 8000的钠的Ped值达到1.00,而Rapidpoint的钠和血红蛋白的Ped值较低。

关键数值与推荐

  • PBQC分析采用EWMA图(λ=0.05),评估假阳性报警率和ANPed,遵循IFCC推荐。
  • Ped值从IQC数据计算,Rapidpoint葡萄糖和COBAS 8000钠的Ped值为1.00,Rapidpoint钠和血红蛋白的Ped值较低。

临床怎么用

  • PBQC可作为常规质控的有效补充,用于早期检测中央实验室和床旁分析仪的分析偏差。
  • 建议将PBQC算法整合入血气分析仪软件,以观察到的偏差触发校准而非固定时间间隔,提高分析可靠性和床旁检测质量保证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Quality control (QC) plays a fundamental role in clinical laboratories by safeguarding the accuracy and reliability of test outcomes. Conventional QC materials often fail to fully reflect patient sample behavior due to matrix differences, leading to non-commutability. Patient-Based Quality Control (PBQC), which evaluates real patient data, offers greater sensitivity for detecting analytical errors. Blood gas analyzers in point-of-care settings rely on frequent automatic calibrations, whereas central laboratory analyzers use operator-driven calibrations. This study compared their analytical performance using PBQC metrics. METHODS: In this retrospective study, patient results for glucose, sodium (Na), and hemoglobin (Hgb) were collected over a three-month period (May-July) at Ümraniye Training and Research Hospital. Data were obtained from central laboratory analyzers (Roche COBAS 8000, Mindray BC6000) and a point-of-care blood gas analyzer (Siemens Rapidpoint 500). A total of 112,898 results were included following the application of three truncation methods based on Reference Interval (RI), RCVG, and the Outlier Q test. PBQC analysis was conducted using Exponentially Weighted Moving Average (EWMA) charts (λ = 0.05) with evaluation of False Positive Flag Rate and average number of patient results before error detection (ANPed), in accordance with IFCC recommendations. Probability of error detection (Ped) values were also calculated from IQC data. RESULTS: PBQC analysis demonstrated that the False Positive Flag Rate was consistently lower in central laboratory analyzers compared to the blood gas analyzer. ANPed values were low in both device types, indicating effective error detection capability. Ped values reached 1.00 for glucose in the Rapidpoint analyzer and sodium in the COBAS 8000, whereas lower Ped values were observed for Rapidpoint sodium and hemoglobin. CONCLUSIONS: PBQC provides an effective complement to conventional QC, enabling early detection of analytical deviations in both central laboratory and point-of-care analyzers. Our findings show that blood gas analyzers, despite frequent automatic calibrations, generate more false positive alerts, whereas central laboratory analyzers demonstrate more stable performance. We propose that PBQC-based algorithms be integrated into blood gas analyzer software, allowing calibrations to be triggered by observed deviations rather than fixed time intervals. Such an approach would enhance analytical reliability and improve quality assurance in point-of-care testing.

来源:Clin Chim Acta,查看原文。版权归原作者所有。

引用

  1. Cavusoglu C. Are frequent calibrations enough? A patient-based quality control perspective on blood gas and laboratory analyzers. Clin Chim Acta. 2025. PMID: 41077272. doi:10.1016/j.cca.2025.120649

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。